| A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) (NCT04941404) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-10 |
| Norepinephrine in Caesarian Section (NCT05264870) | University Hospital, Antwerp | 2022-06-09 |
| A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (NCT05375760) | AstraZeneca | 2022-06-09 |
| Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 (NCT05034874) | InterveXion Therapeutics, LLC | 2022-06-09 |
| PARP Inhibition for Gliomas (PI-4G or π4g) (NCT05297864) | University of Oklahoma | 2022-06-09 |
| PAL to Improve Oral Feeding for Infants With Chronic Lung Disease (NCT05446389) | University of Missouri-Columbia | 2022-06-08 |
| Iron Chelation in the Prevention of Secondary Degeneration After Stroke (NCT05111821) | University Hospital, Bordeaux | 2022-06-08 |
| Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma (NCT05200143) | Providence Health & Services | 2022-06-08 |
| Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep (NCT05301894) | Neurocrine Biosciences | 2022-06-07 |
| Study Assessing Pain Relief After Replacement of the Knee (NCT05260008) | Allay Therapeutics, Inc. | 2022-06-07 |
| A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease (NCT05478031) | reMYND | 2022-06-07 |
| THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) (NCT05033314) | University Health Network, Toronto | 2022-06-07 |
| An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis (NCT05399368) | RAPT Therapeutics, Inc. | 2022-06-07 |
| PET Imaging of Cyclooxygenase in Multiple Sclerosis (NCT05062083) | National Institute of Mental Health (NIMH) | 2022-06-07 |
| A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours (NCT05397171) | AstraZeneca | 2022-06-07 |
| A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia (NCT05268003) | M.D. Anderson Cancer Center | 2022-06-07 |
| Effect of the Antidiabetic Drug Dapagliflozin on the Coronary Macrovascular and Microvascular Function in Type 2 Diabetic Patients (NCT05392959) | Centre Hospitalier Universitaire Saint Pierre | 2022-06-06 |
| A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials (NCT05439941) | Evelo Biosciences, Inc. | 2022-06-06 |
| A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle (NCT05304390) | Fred Hutchinson Cancer Center | 2022-06-06 |
| Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment (NCT05435352) | Ourotech, Inc. | 2022-06-06 |
| Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2 (NCT05438498) | MediMergent, LLC | 2022-06-03 |
| STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia (NCT05490563) | Seelos Therapeutics, Inc. | 2022-06-03 |
| A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor (NCT05366751) | Sage Therapeutics | 2022-06-03 |
| China Surpass Streamline Post-Market Study (NCT05544045) | Stryker Neurovascular | 2022-06-03 |
| Safety and Efficacy of HMI-103 in Participants With Classical PKU Due to PAH Deficiency (NCT05222178) | Homology Medicines, Inc | 2022-06-03 |
| IMM-BCP-01 in Mild to Moderate COVID-19 (NCT05429021) | Immunome, Inc. | 2022-06-03 |
| Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa (NCT05392751) | Endogena Therapeutics, Inc | 2022-06-02 |
| A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease (NCT05310071) | Biogen | 2022-06-02 |
| The Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy (NCT06248970) | Zeng Changhao | 2022-06-01 |
| Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma (NCT06248840) | Zeng Changhao | 2022-06-01 |
| A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment (NCT05243056) | University of Alabama at Birmingham | 2022-06-01 |
| Transcutaneous Auricular Vagus Nerve Stimulation to Enhance Motor Learning (NCT05316519) | VA Pittsburgh Healthcare System | 2022-06-01 |
| Radioembolization in Elderly/ Fragile Patients With mCRC (NCT05092880) | UMC Utrecht | 2022-06-01 |
| Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device (NCT04595903) | Aethlon Medical Inc. | 2022-06-01 |
| Palisade Lateral Branch Technique Using Multi-tined Needles for Sacro-iliac Joint Radiofrequency Ablation (NCT05043961) | Ciusss de L'Est de l'Île de Montréal | 2022-06-01 |
| Angiotensin II for Distributive Shock (NCT04904562) | Northwestern University | 2022-06-01 |
| Long-Term Follow-Up Study of Patients Receiving ATL001 (NCT04785365) | Achilles Therapeutics UK Limited | 2022-06-01 |
| A Clinical Investigation Evaluating Peristeen® Performance (NCT05381610) | Coloplast A/S | 2022-06-01 |
| ParentText User Engagement and Effectiveness Study (NCT05003518) | University of Oxford | 2022-06-01 |
| Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA (NCT05245071) | Sanofi | 2022-06-01 |
| Optimization of Spleen VCTE Examinations with FibroScan (NCT05122416) | Echosens | 2022-06-01 |
| Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study (NCT05430854) | Amgen | 2022-06-01 |
| Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum (NCT05343754) | Erasmus Medical Center | 2022-06-01 |
| Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD (NCT05480566) | Hasselt University | 2022-06-01 |
| Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy (NCT06199778) | Zeng Changhao | 2022-06-01 |
| Intermittent Oral-esophageal Tube Feeding in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma (NCT06189482) | Zeng Changhao | 2022-06-01 |
| Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections (NCT05258851) | King Faisal Specialist Hospital & Research Center | 2022-06-01 |
| Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics (NCT04955470) | University of British Columbia | 2022-06-01 |
| Non-pharmacological Treatments in Migraine. (NCT05596058) | University of Trieste | 2022-06-01 |
| Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors (NCT05452681) | University of Alabama at Birmingham | 2022-06-01 |
| TEAMS-BP (The Enhancement of Social Networks to Augment Management of Stroke-Blood Pressure) (NCT05258890) | Brigham and Women's Hospital | 2022-05-31 |
| Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes (NCT05139914) | Boston University | 2022-05-31 |
| A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma (NCT05121103) | Epizyme, Inc. | 2022-05-31 |
| Erenumab-aooe for the Management of Trigeminal Neuropathic Pain. (NCT05142228) | University of Maryland, Baltimore | 2022-05-31 |
| A Study of DS-9606a in Patients With Advanced Solid Tumors (NCT05394675) | Daiichi Sankyo | 2022-05-31 |
| Atomoxetine in Patients With Tourette's Syndrome (NCT04354103) | Poitiers University Hospital | 2022-05-31 |
| Safety and Performance Evaluation of multiPlus Dialysate During CRRT (NCT05315817) | Fresenius Medical Care Deutschland GmbH | 2022-05-31 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED (NCT05422001) | University of Aarhus | 2022-05-31 |
| Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis (NCT06007508) | HealthPartners Institute | 2022-05-31 |
| Optoacoustic Detection of Inflammation Using MSOT Device (NCT05333978) | University of Oklahoma | 2022-05-31 |
| Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention (NCT05372445) | National Council of Scientific and Technical Research, Argentina | 2022-05-30 |
| A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis (NCT05382715) | Bristol-Myers Squibb | 2022-05-30 |
| Assessment of Emotional Memory During Transient Global Amnesia (NCT04548037) | Centre Hospitalier Universitaire de Nīmes | 2022-05-30 |
| Resolution of Sickle Cell Leg Ulcers With Voxelotor (NCT05561140) | Pfizer | 2022-05-30 |
| REINVENT Registry (Registry of the Nerve Gap Repair From Integra) (NCT05339594) | Integra LifeSciences Corporation | 2022-05-30 |
| vNOTES Salpingo-oophorectomy or Bilateral Salpingectomy Compared With Laparoscopic. (NCT05228938) | HaEmek Medical Center, Israel | 2022-05-29 |
| AsiDNA Children, Adolescents and Young Adults (NCT05394558) | Institut Curie | 2022-05-27 |
| Cleansing Device for the Treatment of Scalp and Hair Conditions (NCT05319444) | University of Minnesota | 2022-05-27 |
| Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors (NCT05309512) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2022-05-27 |
| 3-D Super Resolution Ultrasound Microvascular Imaging (NCT04136912) | UNC Lineberger Comprehensive Cancer Center | 2022-05-26 |
| Effectiveness of CRD-740 in Heart Failure (NCT05409183) | Cardurion Pharmaceuticals, Inc. | 2022-05-26 |
| Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) (NCT05162027) | University of Maryland, Baltimore | 2022-05-26 |
| Implementing 3-Step Workout for Life in Home Health (NCT04709783) | University of Florida | 2022-05-26 |
| Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours (NCT05255484) | LaNova Medicines Limited | 2022-05-26 |
| NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression) (NCT05185037) | Philips Clinical & Medical Affairs Global | 2022-05-26 |
| Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies (NCT05221320) | BioMed Valley Discoveries, Inc | 2022-05-26 |
| Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD) (NCT05415410) | VectivBio AG | 2022-05-25 |
| Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer (NCT04778982) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2022-05-25 |
| Efficacy of Botulinum Toxin A in the Treatment of Bruxism-related Symptomatology (NCT04722809) | Centre Hospitalier Universitaire Dijon | 2022-05-25 |
| CNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC (NCT04739358) | Criterium, Inc. | 2022-05-25 |
| Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy (NCT04932031) | Sapere Bio | 2022-05-25 |
| OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer (NCT05248789) | Binhui Biopharmaceutical Co., Ltd. | 2022-05-25 |
| A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT05077423) | Y-mAbs Therapeutics | 2022-05-25 |
| Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon (NCT05445258) | InnoRa GmbH | 2022-05-25 |
| Biobehavioral Mechanisms of Food Insecurity (NCT04968496) | The Miriam Hospital | 2022-05-24 |
| Acute Pudendal Nerve Stimulation On Leak Point Pressure In Women Urodynamic Early Feasibility Study (NCT05128682) | Corewell Health East | 2022-05-24 |
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| GB5121 in Adult Patients With Relapsed/Refractory CNS Lymphoma (NCT05242146) | GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2022-05-24 |
| Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly (NCT06788236) | Aventi Biotechnology Inc. | 2022-05-23 |
| A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) (NCT05269355) | PTC Therapeutics | 2022-05-23 |
| NT-I7 for Kaposi Sarcoma in Patients With or Without HIV (NCT04893018) | Fred Hutchinson Cancer Center | 2022-05-23 |
| A Phase II Clinical Trial of TQC3721 Suspension for Inhalation (NCT05292196) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-05-20 |
| Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III (NCT05196165) | Ultragenyx Pharmaceutical Inc | 2022-05-20 |
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease (NCT05327803) | AN2 Therapeutics, Inc | 2022-05-20 |
| Can You Reduce Problematic Smartphone Use Through a Group Intervention: A Single Case Experimental Design (NCT05384548) | Canterbury Christ Church University | 2022-05-20 |
| A Study in Patients With Advanced Breast Cancer (NCT04942054) | Sun Pharma Advanced Research Company Limited | 2022-05-20 |
| Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells) (NCT04957602) | Hospices Civils de Lyon | 2022-05-20 |
| Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations (NCT05267106) | Incyte Corporation | 2022-05-20 |
| GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma (NCT05352542) | jianming xu | 2022-05-19 |